作者
Paolo Tarantino,Erika Hamilton,Sara M. Tolaney,Javier Cortes,Stefania Morganti,Emanuela Ferraro,Antonio Marra,Giulia Viale,Dario Trapani,Fátima Cardoso,Frédérique Penault‐Llorca,Giuseppe Viale,Fabrice André,Giuseppe Curigliano
摘要
Article Tools REVIEW ARTICLES Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.19.02488 Journal of Clinical Oncology - published online before print April 24, 2020 PMID: 32330069 HER2-Low Breast Cancer: Pathological and Clinical Landscape Paolo Tarantino, MD1,2xPaolo TarantinoSearch for articles by this author; Erika Hamilton, MD3xErika HamiltonSearch for articles by this author; Sara M. Tolaney, MD, MPH4xSara M. TolaneySearch for articles by this author; Javier Cortes, MD, PhD5,6xJavier CortesSearch for articles by this author; Stefania Morganti, MD1,2xStefania MorgantiSearch for articles by this author; Emanuela Ferraro, MD1,2xEmanuela FerraroSearch for articles by this author; Antonio Marra, MD1,2xAntonio MarraSearch for articles by this author; Giulia Viale, MD1,2xGiulia VialeSearch for articles by this author; Dario Trapani, MD1,2xDario TrapaniSearch for articles by this author; Fatima Cardoso, MD7xFatima CardosoSearch for articles by this author; Frédérique Penault-Llorca, MD, PhD8,9xFrédérique Penault-LlorcaSearch for articles by this author; Giuseppe Viale, MD1,2xGiuseppe VialeSearch for articles by this author; Fabrice Andrè, MD, PhD10xFabrice AndrèSearch for articles by this author; and Giuseppe Curigliano, MD, PhD1,2xGiuseppe CuriglianoSearch for articles by this author Show More 1European Institute of Oncology IRCCS, Milan, Italy2University of Milan, Milan, Italy3Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN4Dana-Farber Cancer Institute, Boston, MA5IOB Institute of Oncology, Quiron Group, Madrid and Barcelona, Spain6Vall d’Hebron Institute of Oncology, Barcelona, Spain7Breast Unit Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal8Jean Perrin Comprehensive Cancer Center, Department of Pathology and Tumor Biology, Centre Jean Perrin, Clermont-Ferrand, France9UMR INSERM 1240 IMoST, Université Clermont Auvergne, Villejuif, France10Department of Medical Oncology, Gustave Roussy, Villejuif, FranceF.A. and G.C. contributed equally to this work. https://doi.org/10.1200/JCO.19.02488 First Page Full Text PDF Figures and Tables © 2020 by American Society of Clinical Oncology